Results 21 to 30 of about 43,736 (227)

Organothiophosphate Induced Acute and Reversible Parkinsonism: Case Report and Literature Review [PDF]

Asia Pacific Journal of Medical Toxicology, 2021
Introduction: Organophosphate compound poisoning is one of the most common causes for admission to the Medical Intensive Care Unit. Parkinsonism is a primary neurotoxic manifestation of organophosphate intoxication.
PRASHANT THAKUR, C SELVAKUMAR, V Kumar
doaj   +1 more source

R2 Demographic data and its relation to clinical improvement in parkinsonian patients subjected to rTMS [PDF]

Minia Journal of Medical Research, 2023
Introduction: Parkinsonism is a group of disorders characterized by bradykinesia, tremors, rigidity, postural instability and other non-motor manifestations.
W Soliman, Ahmed Ali, Mohamed Abdelkader, Baraah Soliman   +3 more
doaj   +1 more source

Focused ultrasound and deep brain stimulation for Parkinsonism – Review of literature to investigate tradeoff between safety and efficacy

Saudi Journal for Health Sciences, 2022
Parkinsonism is a movement disorder, mostly caused by the neurodegenerative Parkinson's disease (PD), the second most common movement disorder. Its symptoms include rigidity, slow movement, tremor, and disruption of balance.
Uthman Alshenqiti, Yasir Alzalabani, Khawar Siddiqui, Saud Alfaisal, Muayad Albadrani   +4 more
doaj   +1 more source

Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models

Journal of Tissue Engineering, 2021
Mesenchymal stem cells (MSCs) are a potential source of cell-based disease-modifying therapy in Parkinsonian disorders. A promising approach to develop in vitro culture methods that mimic natural MSC niche is cell priming.
Ha Na Kim, Jin Young Shin, Dong Yeol Kim, Ji Eun Lee, Phil Hyu Lee   +4 more
doaj   +1 more source

Voice and Speech in Atypical Parkinsonian Disorders

Movement Disorders Clinical Practice
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA).
Federico Rodriguez‐Porcel, Farwa Ali, Michiko Bruno, Heather Davis Cuevas, Rohit Dhall, Kylie Dunne‐Platero, Lawrence I. Golbe, Ihtsham Haq, Nicole Herndon, Lawrence S. Honig, Kyurim Kang, Sarah Kremen, Guillaume Lamotte, Nikolaus R. McFarland, Michela Mir, Leila Montaser‐Kouhsari, Alexander Pantelyat, Joel Page, Hylan Pickett, Laura Purcell Verdun, Kelly Richardson, Jessica Shurer, Michelle Troche, Rene L. Utianski, Katya Villarreal‐Cavazos, Tuhin Virmani, Anne‐Marie Wills   +26 more
openaire   +3 more sources

Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism

EJNMMI Research, 2021
Background The functional 6-[18F]FDOPA positron emission tomography (PET) can be a helpful tool in differentiating parkinsonism with dopaminergic deficiency from clinically similar differential diagnoses.
Enrico Michler, Daniel Kaiser, Kiriaki Eleftheriadou, Björn Falkenburger, Jörg Kotzerke, Sebastian Hoberück   +5 more
doaj   +1 more source

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2019
Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative ...
Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau   +29 more
doaj   +1 more source

Relationship Between Swallowing Function and Maximum Phonation Time in Patients With Parkinsonism [PDF]

Annals of Rehabilitation Medicine, 2018
Objective To identify the relationship between maximum phonation time (MPT) and swallowing function, as well as the elements of swallowing, in order to provide a rationale for speech therapy in patients with Parkinsonism manifesting dysphagia.
Eu Jeong Ko, Minji Chae, Sung-Rae Cho
doaj   +1 more source

Progress on diagnosis and treatment of functional parkinsonism

Chinese Journal of Contemporary Neurology and Neurosurgery, 2023
Functional parkinsonism (FP) is a disorder caused by psychological factors rather than neurodegeneration. Functional parkinsonism has a great influence on patients' quality of life and daily function. However, due to overlapping with some of the symptoms
HUANG Pei, WANG Gang
doaj   +1 more source

Diagnostic Evaluation of 99mTc-TRODAT-1 SPECT in Parkinsonism [PDF]

Journal of Research in Clinical Medicine, 2021
Background Parkinsonism as a group of movement disorders, exhibit similar clinical presentation. Therefore, clinically differentiating these diseases is difficult. We investigated the diagnostic value of 99m Tc-TRODAT-1 SPECT in this setting.
Zahra Babaei Aghdam, Safa Najmi Tabrizi, Amin Arasteh, Mohammad Khalafi, Morteza Ghojazadeh, Babak Mahmoudian   +5 more
doaj   +1 more source